PAS
RMD icon

Park Avenue Securities’s ResMed RMD Stock Holding History

Park Avenue Securities’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$479K Sell
2,460
-2,223
-47% -$461K ﹤0.01% 1314
2026
Q1 		$1.05M Buy
+4,683
New +$1.17M 0.01% 789
2025
Q4 		– Sell
-5,254
Closed -$1.44M – 1662
2025
Q3 		$1.44M Sell
5,254
-130
-2% -$35.5K 0.01% 728
2025
Q2 		$1.39M Buy
+5,384
New +$1.28M 0.01% 648
2025
Q1 		– Sell
-4,431
Closed -$1.01M – 1453
2024
Q4 		$1.01M Buy
4,431
+2,228
+101% +$536K 0.01% 753
2024
Q3 		$538K Sell
2,203
-80
-4% -$17.9K 0.01% 945
2024
Q2 		$437K Buy
2,283
+17
+0.8% +$3.45K 0.01% 1023
2024
Q1 		$449K Buy
2,266
+382
+20% +$70K 0.01% 1011
2023
Q4 		$324K Buy
1,884
+208
+12% +$32K ﹤0.01% 1093
2023
Q3 		$248K Buy
+1,676
New +$303K ﹤0.01% 1137
2023
Q1 		– Sell
-3,128
Closed -$651K – 1067
2022
Q4 		$651K Buy
3,128
+67
+2% +$14.7K 0.01% 684
2022
Q3 		$668K Sell
3,061
-435
-12% -$99K 0.01% 617
2022
Q2 		$733K Buy
3,496
+300
+9% +$63.9K 0.01% 572
2022
Q1 		$775K Buy
3,196
+28
+0.9% +$6.77K 0.01% 573
2021
Q4 		$825K Buy
3,168
+82
+3% +$21.3K 0.01% 535
2021
Q3 		$813K Sell
3,086
-106
-3% -$29K 0.02% 497
2021
Q2 		$787K Buy
3,192
+20
+0.6% +$4.21K 0.02% 484
2021
Q1 		$615K Buy
3,172
+13
+0.4% +$2.61K 0.01% 517
2020
Q4 		$671K Sell
3,159
-261
-8% -$52K 0.02% 429
2020
Q3 		$586K Sell
3,420
-106
-3% -$19.6K 0.02% 397
2020
Q2 		$677K Buy
+3,526
New +$577K 0.03% 270
2020
Q1 		– Sell
-3,673
Closed -$569K – 535
2019
Q4 		$569K Buy
3,673
+492
+15% +$70.9K 0.02% 268
2019
Q3 		$430K Buy
+3,181
New +$417K 0.02% 278
2019
Q2 		– Sell
-2,862
Closed -$300K – 428
2019
Q1 		$300K Buy
+2,862
New +$295K 0.02% 307

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Park Avenue Securities's RMD Position: Q2 2026 in Review

Park Avenue Securities reduced its ResMed (RMD) stake by 47% in Q2 2026, selling an estimated $461K and leaving 2,460 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #1314.

Park Avenue Securities first reported a position in RMD in Q1 2019 and has held it in 24 quarters since. The position peaked at $1.44M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Park Avenue Securities held 2,460 shares of ResMed worth $479K as of Q2 2026.
  • Park Avenue Securities sold 2,223 ResMed shares in Q2 2026, an estimated $461K.
  • ResMed made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1314 holding.
  • Park Avenue Securities first reported a position in ResMed in Q1 2019 and has held it in 24 quarters since.
  • Park Avenue Securities's ResMed position peaked at $1.44M in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.